Literature DB >> 17468353

Risk factors for mortality among patients with diabetes: the Translating Research Into Action for Diabetes (TRIAD) Study.

Laura N McEwen1, Catherine Kim, Andrew J Karter, Mary N Haan, Debashis Ghosh, Paula M Lantz, Carol M Mangione, Theodore J Thompson, William H Herman.   

Abstract

OBJECTIVE: We sought to examine demographic, socioeconomic, and biological predictors of all-cause, cardiovascular, and noncardiovascular mortality in patients with diabetes. RESEARCH DESIGN AND METHODS: Survey, medical record, and administrative data were obtained from 8,733 participants in the Translating Research Into Action for Diabetes Study, a multicenter, prospective, observational study of diabetes care in managed care. Data on deaths (n = 791) and cause of death were obtained from the National Death Index after 4 years. Predictors examined included age, sex, race, education, income, duration, and treatment of diabetes, BMI, smoking, microvascular and macrovascular complications, and comorbidities.
RESULTS: Predictors of adjusted all-cause mortality included older age (hazard ratio [HR] 1.04 [95% CI 1.03-1.05]), male sex (1.57 [1.35-1.83]), lower income (< $15,000 vs. > $75,000, HR 1.82 [1.30-2.54]; $15,000-$40,000 vs. > $75,000, HR 1.58 [1.15-2.17]), longer duration of diabetes (> or = 9 years vs. < 9 years, HR 1.20 [1.02-1.41]), lower BMI (< 26 vs. 26-30 kg/m2, HR 1.43 [1.13-1.69]), smoking (1.44 [1.20-1.74]), nephropathy (1.46 [1.23-2.73]), macrovascular disease (1.46 [1.23-1.74]), and greater Charlson index (> or = 2-3 vs. < 1, HR 2.01 [1.04-3.90]; > or = 3 vs. < 1, HR 4.38 [2.26-8.47]). The predictors of cardiovascular and noncardiovascular mortality were different. Macrovascular disease predicted cardiovascular but not noncardiovascular mortality.
CONCLUSIONS: Among people with diabetes and access to medical care, older age, male sex, smoking, and renal disease are important predictors of mortality. Even within an insured population, socioeconomic circumstance is an important independent predictor of health.

Entities:  

Mesh:

Year:  2007        PMID: 17468353     DOI: 10.2337/dc07-0305

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  44 in total

1.  Charlson comorbidity index helps predict the risk of mortality for patients with type 2 diabetic nephropathy.

Authors:  You-qun Huang; Rong Gou; Yong-shu Diao; Qing-hua Yin; Wen-xing Fan; Ya-ping Liang; Yi Chen; Min Wu; Li Zang; Ling Li; Jing Zang; Lu Cheng; Ping Fu; Fang Liu
Journal:  J Zhejiang Univ Sci B       Date:  2014-01       Impact factor: 3.066

2.  Measuring Emergency Care Survival: The Implications of Risk-Adjusting for Race and Poverty.

Authors:  Kimon L H Ioannides; Avi Baehr; David N Karp; Douglas J Wiebe; Brendan G Carr; Daniel N Holena; M Kit Delgado
Journal:  Acad Emerg Med       Date:  2018-05-31       Impact factor: 3.451

Review 3.  The obesity paradox in diabetes.

Authors:  Mercedes R Carnethon; Laura J Rasmussen-Torvik; Latha Palaniappan
Journal:  Curr Cardiol Rep       Date:  2014-02       Impact factor: 2.931

4.  Association of weight status with mortality in adults with incident diabetes.

Authors:  Mercedes R Carnethon; Peter John D De Chavez; Mary L Biggs; Cora E Lewis; James S Pankow; Alain G Bertoni; Sherita H Golden; Kiang Liu; Kenneth J Mukamal; Brenda Campbell-Jenkins; Alan R Dyer
Journal:  JAMA       Date:  2012-08-08       Impact factor: 56.272

5.  Predicting 5- and 10-Year Mortality Risk in Older Adults With Diabetes.

Authors:  Kevin N Griffith; Julia C Prentice; David C Mohr; Paul R Conlin
Journal:  Diabetes Care       Date:  2020-06-19       Impact factor: 19.112

6.  Cardiovascular outcome ascertainment was similar using blinded and unblinded adjudicators in a national prospective study.

Authors:  Gaurav Parmar; Pallavi Ghuge; Jewell H Halanych; Ellen Funkhouser; Monika M Safford
Journal:  J Clin Epidemiol       Date:  2010-04-28       Impact factor: 6.437

7.  Racial disparities in cardiovascular risk factor control in an underinsured population with Type 2 diabetes.

Authors:  Y Wang; P T Katzmarzyk; R Horswell; W Zhao; W Li; J Johnson; D H Ryan; G Hu
Journal:  Diabet Med       Date:  2014-04-30       Impact factor: 4.359

8.  Socioeconomic position and cardiovascular disease in adults with and without diabetes: United States trends, 1997-2005.

Authors:  Rosemary Dray-Spira; Tiffany L Gary; Frederick L Brancati
Journal:  J Gen Intern Med       Date:  2008-07-31       Impact factor: 5.128

9.  Educational disparities in mortality among adults with diabetes in the U.S.

Authors:  Rosemary Dray-Spira; Tiffany L Gary-Webb; Frederick L Brancati
Journal:  Diabetes Care       Date:  2010-03-03       Impact factor: 19.112

10.  Predictors and impact of intensification of antihyperglycemic therapy in type 2 diabetes: translating research into action for diabetes (TRIAD).

Authors:  Laura N McEwen; Dori Bilik; Susan L Johnson; Jeffrey B Halter; Andrew J Karter; Carol M Mangione; Usha Subramanian; Beth Waitzfelder; Jesse C Crosson; William H Herman
Journal:  Diabetes Care       Date:  2009-02-19       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.